SRS Capital Advisors »

Arrivent Biopharma shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.2k 119 18.55

More positions owned by SRS Capital Advisors

Ishares Tr Ishs 1-5yr Invs (IGSB)
Vanguard Index Fds Growth Etf (VUG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Value Etf (VTV)
Schwab Strategic Tr Us Tips Etf (SCHP)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Iboxx Inv Cp Etf (LQD)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr Rus 2000 Grw Etf (IWO)

View all positions for SRS Capital Advisors

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
OrbiMed Advisors
FMR
Octagon Capital Advisors
Suvretta Capital Management
Sofinnova Ventures
Novo A/S
General Catalyst Group Management
Sc China Holding
BlackRock
Vanguard Group
Cormorant Asset Management
Perceptive Advisors
Geode Capital Management
State Street Corporation

View all funds holding Arrivent Biopharma